AXT (AXTI) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to a loss of $0.15 per share a year ago.
AXT NASDAQ: AXTI reported record second-quarter revenue and a return to profitability, driven by strong demand for indium phosphide substrates used in optical connectivity for AI data centers. Management said it is accelerating capacity expansion as customer demand continues to exceed supply.
AXT heads into Q2 earnings with a record InP backlog and AI-driven demand, but export risks, rich valuation and trade tensions warrant caution.
AXT (AXTI) now trades well below its recent equity offering price, presenting a compelling value and a strong buy opportunity ahead of Q2 2026 earnings. I anticipate Q2 2026 will confirm accelerating revenue, margin recovery, a robust $100M+ backlog, and a potential inflection to profitability. Management guides for $34M revenue and $0.06–$0.08 non-GAAP EPS, with Indium Phosphide revenue expected to exceed $17M, breaking company records.
AXT (AXTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AXTI is expanding InP capacity and advancing 6-inch wafers to target co-packaged optics opportunities expected to emerge from late 2027.
AXT's drop below its 50-day SMA reflects export delays and cash-flow risks, but record InP backlog and AI demand support retaining the stock.
AXT is accelerating InP capacity expansion through 2028 as AI optical demand, a $100M-plus backlog and Tier-1 adoption point to multi-year growth.
AXTI's China AI demand is surging as indium phosphide sales jump, but rising geopolitical tensions could shape its next growth phase.
AXTI could post its biggest-ever Indium Phosphide quarter in Q2 2026 as AI demand surges and a record backlog boosts revenue visibility.
AXT is riding on the AI-driven optical networking boom as rising InP demand, capacity expansion, and a $100M backlog position it for long-term growth.
AXT's indium phosphide backlog tops $100M as AI-driven demand surges, but export approvals remain the key factor shaping growth.